文献速递类风湿关节炎

类风湿关节炎抑郁和焦虑筛查量表的效度与信度

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-07-08

该研究在150例类风湿关节炎(RA)患者中,以SCID-1诊断为金标准,评估多种抑郁和焦虑筛查工具的效度与信度。抑郁筛查工具诊断性能良好,焦虑工具表现不一;重测信度良好(ICC 0.69–0.88)。筛查阳性者需临床确认。

要点

  • 抑郁筛查工具敏感性和特异性良好,阴性预测值高。
  • 焦虑筛查工具诊断性能差异较大,需谨慎解读。
  • 所有筛查阳性结果均需临床确认,不能直接诊断。

核心结论

  • 抑郁筛查工具在RA患者中诊断性能良好,焦虑筛查工具表现不一。
  • 筛查发现的抑郁和焦虑需要临床确认。

研究设计与样本

  • 纳入150例RA患者,完成多种抑郁和焦虑筛查量表。
  • 以SCID-1研究版诊断作为金标准,计算敏感度、特异度、预测值及重测信度。

主要发现

  • 11.3%患者有SCID-1诊断的抑郁,7.3%有广泛性焦虑障碍,19.3%有任何焦虑障碍。
  • 抑郁筛查敏感度从HADS-D(切点11)的35%到PHQ-2的88%和PHQ-9的87%。
  • 抑郁筛查特异度从PHQ-9的77%和PHQ-2的84%到HADS-D(切点11)的94%。
  • 抑郁筛查阳性预测值30%–43%,阴性预测值92%–98%。
  • 广泛性焦虑障碍筛查敏感度从HADS-A(切点11)的45%到HADS-A(切点8)的91%;除HADS-A(切点8)特异度63%外,其余工具特异度81%–89%。

关键数值与推荐

  • 抑郁:HADS-D切点11敏感度35%、特异度94%;PHQ-2敏感度88%、特异度84%;PHQ-9敏感度87%、特异度77%。
  • 广泛性焦虑障碍:HADS-A切点11敏感度45%;HADS-A切点8敏感度91%、特异度63%。
  • 重测信度ICC范围0.69–0.88。

临床怎么用

  • RA患者可使用抑郁筛查工具如PHQ-2或PHQ-9进行初筛,阳性者需临床确认。
  • 焦虑筛查工具性能不一,解读结果时应结合临床评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the validity and reliability of screening instruments for depression and anxiety in rheumatoid arthritis (RA). METHODS: Participants with RA completed the Patient Health Questionnaire (PHQ-2 or PHQ-9), the Patient Reported Outcomes Measurement Information System depression short form 8a and anxiety short form 8a, the Hospital Anxiety and Depression Scale anxiety score (HADS-A) and depression score (HADS-D), the Overall Anxiety Severity and Impairment Scale, the Generalized Anxiety Disorder 2- and 7-item scales, and the Kessler-6 scale. Clinical depression and anxiety disorders were confirmed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Axis I Disorders (SCID-1) research version. We reported sensitivity, specificity, positive predictive value, and negative predictive value using SCID-1 diagnoses as the criterion standard. Test-retest reliability was assessed with the intraclass correlation coefficient. RESULTS: Of 150 participants, 11.3% had SCID-1-diagnosed depression, 7.3% had SCID-1-diagnosed generalized anxiety disorder, and 19.3% had any SCID-1-diagnosed anxiety disorder. For depression, sensitivity ranged from HADS-D (cut point 11; 35%) to PHQ-2 (88%) and PHQ-9 (87%). Specificity ranged from PHQ-9 (77%) and PHQ-2 (84%) to HADS-D (cut point 11; 94%). Positive predictive value ranged from 30% to 43%. Negative predictive value ranged from 92% to 98%. For generalized anxiety disorder, sensitivity ranged from HADS-A (cut point 11; 45%) to HADS-A (cut point 8; 91%). Specificity ranged from 81% to 89% for all measures except the HADS-A (cut point 8; 63%). Intraclass correlation coefficient estimates ranging from 0.69 to 0.88 confirmed good test-retest reliability. CONCLUSION: Depression screening instruments had good diagnostic performance; anxiety instruments were more variable. Identified depression and anxiety require clinical confirmation.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Hitchon CA, Zhang L, Peschken CA, et al. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2020. PMID: 31199570. doi:10.1002/acr.24011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。